231 related articles for article (PubMed ID: 27811209)
1. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
Díaz-Garzón J; Sandoval Y; Smith SW; Love S; Schulz K; Thordsen SE; Johnson BK; Driver B; Jacoby K; Carlson MD; Dodd KW; Moore J; Scott NL; Bruen CA; Hatch R; Apple FS
Clin Chem; 2017 Jan; 63(1):415-419. PubMed ID: 27811209
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.
Nestelberger T; Boeddinghaus J; Lopez-Ayala P; Kaier TE; Marber M; Gysin V; Koechlin L; Sanchez AY; Giménez MR; Wussler D; Walter JE; Strebel I; Zimmermann T; Glarner N; Miró Ò; Martin-Sanchez FJ; Zehnder T; Twerenbold R; Keller DI; Mueller C;
JAMA Cardiol; 2021 Jul; 6(7):771-780. PubMed ID: 33881449
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
[TBL] [Abstract][Full Text] [Related]
7. Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction.
Rocheleau S; Eng-Frost J; Lambrakis K; Khan E; Chiang B; Wattchow N; Steele S; Lorensini S; Lehman SJ; Papendick C; Chew DP
Heart Lung Circ; 2023 Aug; 32(8):978-985. PubMed ID: 37225600
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
[TBL] [Abstract][Full Text] [Related]
10. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
[TBL] [Abstract][Full Text] [Related]
11. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
Kassem M; Ayala PL; Andric-Cancarevic T; Tajsic M; Vargas KG; Bendik D; Kaufmann C; Wojta J; Mueller C; Huber K
Int J Cardiol; 2024 May; 403():131879. PubMed ID: 38369132
[TBL] [Abstract][Full Text] [Related]
12. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
[TBL] [Abstract][Full Text] [Related]
13. Pseudo-targeted metabolic profile differences between emergency patients with type 1 and type 2 myocardial infarction diagnosed by optical coherence tomography.
Wang J; Li Z; Yang G; Fang C; Yin Y; Zheng Z; Wang H; Fang S; Dai J; Wang S; Yang S; Yu B
Clin Chim Acta; 2024 Feb; 554():117745. PubMed ID: 38185283
[TBL] [Abstract][Full Text] [Related]
14. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes.
Schulte C; Singh B; Theofilatos K; Sörensen NA; Lehmacher J; Hartikainen T; Haller PM; Westermann D; Zeller T; Blankenberg S; Neumann JT; Mayr M
J Mol Cell Cardiol Plus; 2022 Sep; 1():None. PubMed ID: 36185590
[TBL] [Abstract][Full Text] [Related]
15. Appropriateness of Cardiac Troponin Testing: Insights from the Use of TROPonin In Acute coronary syndromes (UTROPIA) Study.
Sandoval Y; Gunsolus IL; Smith SW; Sexter A; Thordsen SE; Carlson MD; Johnson BK; Bruen CA; Dodd KW; Driver BE; Jacoby K; Love SA; Moore JC; Scott NL; Schulz K; Apple FS
Am J Med; 2019 Jul; 132(7):869-874. PubMed ID: 30849383
[TBL] [Abstract][Full Text] [Related]
16. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey.
Yao H; Cottin Y; Chagué F; Maza M; Bichat F; Zeller M; Putot A
Am Heart J; 2023 Dec; 266():86-97. PubMed ID: 37703947
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of High Sensitivity Compared with Contemporary Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction.
Sandoval Y; Smith SW; Thordsen SE; Bruen CA; Carlson MD; Dodd KW; Driver BE; Jacoby K; Johnson BK; Love SA; Moore JC; Sexter A; Schulz K; Scott NL; Nicholson J; Apple FS
Clin Chem; 2017 Oct; 63(10):1594-1604. PubMed ID: 28701316
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
White K; Kinarivala M; Scott I
BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
[TBL] [Abstract][Full Text] [Related]
20. Type 1 or Type 2 Myocardial Infarction in Patients with a History of Coronary Artery Disease: Data from the Emergency Department.
Putot A; Jeanmichel M; Chagué F; Avondo A; Ray P; Manckoundia P; Zeller M; Cottin Y
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31810178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
